Evidence map›Paper›PMID 29942082›Full record

ArticleNature genetics2018

De novo variants in neurodevelopmental disorders with epilepsy.

Henrike O Heyne, Tarjinder Singh, Hannah Stamberger, Rami Abou Jamra, Hande Caglayan, Dana Craiu, Peter De Jonghe, Renzo Guerrini, Katherine L Helbig, Bobby P C Koeleman and 20 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 161 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed, 3 pooled it
27.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 3 syntheses or guidelines pooled it, 312 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Characterization of Three Distinct Loss-of-Function Cav2.3 Variants.International journal of molecular sciences · 2026
    Article
  10. A De NovoInternational journal of molecular sciences · 2026
    Article
  11. Article
  12. Article
  13. Novel Variants Identified in Families With SNX27 -Related Neurodevelopmental Disorder, Aiding in Characterizing Its Genotypic and Phenotypic Spectrum.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2026
    Article
  14. Genetic insights on the mechanisms of human cortical folding.bioRxiv : the preprint server for biology · 2026
    Article
  15. Shared and distinct phenotypic profiles among neurodevelopmental disorder genes.medRxiv : the preprint server for health sciences · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Synaptobrevin-2 disease variants reveal spatial constraints within the presynaptic active zone.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 18 institutions in 11 countries.

Henrike O HeyneUniversity of Leipzig Hospitals and Clinics, Leipzig, Germany. hheyne@broadinstitute.org.
Tarjinder SinghProgram in Medical and Population Genetics, and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-0601-6815
Hannah StambergerNeurogenetics Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.
Rami Abou JamraUniversity of Leipzig Hospitals and Clinics, Leipzig, Germany.ORCID http://orcid.org/0000-0002-1542-1399
Hande CaglayanDepartment of Molecular Biology and Genetics, Bogaziçi University, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-6402-3306
Dana Craiu'Carol Davila' University of Medicine Bucharest, Department of Clinical Neurosciences (No. 6), Pediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania.
Peter De JongheNeurogenetics Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.
Renzo GuerriniPediatric Neurology and Neurogenetics Unit and Laboratories, A. Meyer Children's Hospital-University of Florence, Florence, Italy.
Katherine L HelbigDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-8249-0549
Bobby P C KoelemanDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Jack A KosmickiProgram in Medical and Population Genetics, and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
Tarja LinnankiviDepartment of Pediatric Neurology, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Patrick MayLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.ORCID http://orcid.org/0000-0001-8698-3770
Hiltrud MuhleDepartment of Neuropediatrics, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Rikke S MøllerDanish Epilepsy Centre, Dianalund, Denmark.
Bernd A NeubauerDepartment of Pediatric Neurology, University Hospital Giessen, Giessen, Germany.
Aarno PalotieProgram in Medical and Population Genetics, and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
Manuela PendziwiatDepartment of Neuropediatrics, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Pasquale StrianoPediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health, University of Genoa 'G. Gaslini' Institute, Genoa, Italy.
Sha TangDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Sitao WuDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
EuroEPINOMICS RES Consortium
Annapurna PoduriEpilepsy Genetics Program, Department of Neurology, Division of Epilepsy and Clinical Neurophysiology, Boston Children's Hospital, Boston, MA, USA.
Yvonne G WeberDepartment of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Sarah WeckhuysenNeurogenetics Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-2878-1147
Sanjay M SisodiyaDepartment of Clinical and Experimental Epilepsy, NIHR, University College London Hospitals Biomedical Research Centre, UCL Institute of Neurology, London, UK.
Mark J DalyProgram in Medical and Population Genetics, and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-0949-8752
Ingo HelbigDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Dennis LalProgram in Medical and Population Genetics, and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
Johannes R LemkeUniversity of Leipzig Hospitals and Clinics, Leipzig, Germany. johannes.lemke@medizin.uni-leipzig.de.ORCID http://orcid.org/0000-0002-4435-6610
Broad Institute · USUniversity of Antwerp · BEAmbry Genetics (United States) · USChildren's Hospital of Philadelphia · USChristian-Albrechts-Universität zu Kiel · DEUniversity Hospital Leipzig · DEBoğaziçi University · TRBoston Children's Hospital · USCarol Davila University of Medicine and Pharmacy · ROHertie Institute for Clinical Brain Research · DEMeyer Children's Hospital · ITUCL Biomedical Research Centre · GBUniversitätsklinikum Gießen und Marburg · DEUniversity Medical Center Utrecht · NLUniversity of Genoa · ITUniversity of Helsinki · FIUniversity of Luxembourg · LUUniversity of Southern Denmark · DK

Funding

Medical Research Council MR/J011231/1
6 · The paper itself

Abstract

Epilepsy is a frequent feature of neurodevelopmental disorders (NDDs), but little is known about genetic differences between NDDs with and without epilepsy. We analyzed de novo variants (DNVs) in 6,753 parent-offspring trios ascertained to have different NDDs. In the subset of 1,942 individuals with NDDs with epilepsy, we identified 33 genes with a significant excess of DNVs, of which SNAP25 and GABRB2 had previously only limited evidence of disease association. Joint analysis of all individuals with NDDs also implicated CACNA1E as a novel disease-associated gene. Comparing NDDs with and without epilepsy, we found missense DNVs, DNVs in specific genes, age of recruitment, and severity of intellectual disability to be associated with epilepsy. We further demonstrate the extent to which our results affect current genetic testing as well as treatment, emphasizing the benefit of accurate genetic diagnosis in NDDs with epilepsy.

Indexed as

EpilepsyExomeFemaleGenetic Predisposition to DiseaseGenetic TestingGenetic VariationHumansIntellectual DisabilityMaleNeurodevelopmental Disorders

Identifiers

PMID29942082
OpenAlexW2809226260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.